Shinji Nakamichi

Inhibition of ABCB1 Overcomes Cancer Stem Cell–like Properties and Acquired Resistance to MET Inhibitors in Non–Small Cell Lung Cancer

Teppei Sugano, Masahiro Seike, Rintaro Noro et al. · Molecular Cancer Therapeutics · 2015 · 76 citations

Medicine, Oncology, Pharmacology +16

Short Hydration in Chemotherapy Containing Cisplatin (>=75 mg/m2) for Patients with Lung Cancer: A Prospective Study

Hidehito Horinouchi, Kayoko Kubota, Hidetoshi Itani et al. · Japanese Journal of Clinical Oncology · 2013 · 62 citations · Full text

Medicine, Oncology, Pharmacology +12

Epidermal Growth Factor Receptor Mutation Is Associated With Longer Local Control After Definitive Chemoradiotherapy in Patients With Stage III Nonsquamous Non–Small-Cell Lung Cancer

Shigehiro Yagishita, Hidehito Horinouchi, Tomoko Taniyama et al. · International Journal of Radiation Oncology*Biology*Physics · 2014 · 62 citations

Medicine, Oncology, Radiation Oncology +14

A phase 1 and dose-finding study of LY2523355 (litronesib), an Eg5 inhibitor, in Japanese patients with advanced solid tumors

Hiroshi Wakui, Noboru Yamamoto, Satoru Kitazono et al. · Cancer Chemotherapy and Pharmacology · 2014 · 58 citations

Medicine, Oncology, Pharmacology +6

A phase 1 study of lenvatinib, multiple receptor tyrosine kinase inhibitor, in Japanese patients with advanced solid tumors

Shinji Nakamichi, Hiroshi Nokihara, Noboru Yamamoto et al. · Cancer Chemotherapy and Pharmacology · 2015 · 56 citations · Full text

Medicine, Oncology, Pharmacology +17